Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
Background/Purpose: Long-term nucleos(t)ide analog (NA) therapy has been shown to improve the survival in patients with HBV-related cirrhosis. The aim of this study was to evaluate the clinical outcomes and factors associated with survival in HBV-related cirrhotic patients receiving long-term NA tre...
Main Authors: | Chih-Lin Lin, Kuo-Chih Tseng, Kuan-Yang Chen, Li-Ying Liao, Jia-Horng Kao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664620302928 |
Similar Items
-
Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs
by: Ming-Chao Tsai, et al.
Published: (2017-07-01) -
The Denver Tube Combined with Antiviral Drugs In the Treatment of HBV-related Cirrhosis with Refractory Ascites: A Report of Three Cases
by: Wang Xiao-jin, et al.
Published: (2014-03-01) -
Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent
by: Jing‐Houng Wang, et al.
Published: (2019-11-01) -
External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
by: Honglian Gui, et al.
Published: (2021-08-01) -
Antiviral Effects of Different Nucleos(t)ide Antiviral Drugs in Patients with Decompensated Hepatitis B Virus-Related Cirrhosis
by: Lei CAI, et al.
Published: (2016-09-01)